Protective roles for myeloid cells in neuroinflammation
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Authors: Owens, Trevor; Benmamar-Badel, Anouk; Wlodarczyk, Agnieszka; Marczynska, Joanna; Morch, Marlene T.; Dubik, Magdalena; Arengoth, Dina S.; Asgari, Nasrin; Webster, Gill; Khorooshi, Reza
Abstract
Myeloid cells represent the major cellular component of innate immune responses. Myeloid cells include monocytes and macrophages, granulocytes (neutrophils, basophils and eosinophils) and dendritic cells (DC). The role of myeloid cells has been broadly described both in physiological and in pathological conditions. All tissues or organs are equipped with resident myeloid cells, such as parenchymal microglia in the brain, which contribute to maintaining homeostasis. Moreover, in case of infection or tissue damage, other myeloid cells such as monocytes or granulocytes (especially neutrophils) can be recruited from the circulation, at first to promote inflammation and later to participate in repair and regeneration. This review aims to address the regulatory roles of myeloid cells in inflammatory diseases of the central nervous system (CNS), with a particular focus on recent work showing induction of suppressive function via stimulation of innate signalling in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
Modulation in the expression of type 1 (CR1/CD35) and type 3 (CR3/CD11b) complement receptors on leukocytes from patients with Visceral leishmaniasis
EXPERIMENTAL PARASITOLOGY
Authors: Campelo, Cassio Marinho; Pinheiro, Igor Carvalho; Tavares, Bruno de Melo; de Lima Henn, Guilherme Alves; Fernandes, Camila; Albuquerque-Pinto, Luiz Carlos; Carneiro Camara, Lilia Maria
Abstract
Visceral leishmaniasis (VL) is an anthropozoonosis endemic in Brazil. We included 20 patients with confirmed diagnosis of VL and 20 healthy individuals to evaluate the expression levels of complement receptor 1 (CR1)/CD35 and CR3/CD11b on leukocytes in the peripheral blood and determine their correlation with the clinical state of patients. CR1/CD35 expression increased on CD11b(+)CD35(+) granulocytes of patients, while CR1/CD35 and CR3/CD11b expression levels increased on CD14(+)CD11b(+)CD35(+) monocytes. Among patients, those with severe clinical state had higher expression of CR3/CD11b on CD14(+)monocytes. The count of CD19(+)CD35(+)b lymphocytes reduced in the blood samples from patients. These observed changes may indicate the modulation in CR1/CD35 and CR3/CD11b complement receptor expressionlevels on granulocyte and monocyte populations in response to Leishmania sp.